V011-5543 Screening compound: 4-tert-butyl-N-(4-{4-oxo-3-[2-(propan-2-yl)phenyl]-1,3-thiazolidin-2-yl}phenyl)benzamide

V011-5543 Screening compound: 4-tert-butyl-N-(4-{4-oxo-3-[2-(propan-2-yl)phenyl]-1,3-thiazolidin-2-yl}phenyl)benzamide
V011-5543 Screening compound: 4-tert-butyl-N-(4-{4-oxo-3-[2-(propan-2-yl)phenyl]-1,3-thiazolidin-2-yl}phenyl)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V011-5543
4-tert-butyl-N-(4-{4-oxo-3-[2-(propan-2-yl)phenyl]-1,3-thiazolidin-2-yl}phenyl)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V011-5543

Molecular Formula

C29H32N2O2S (C29 H32 N2 O2 S)

Compound Name

4-tert-butyl-N-(4-{4-oxo-3-[2-(propan-2-yl)phenyl]-1,3-thiazolidin-2-yl}phenyl)benzamide

IUPAC name

4-tert-butyl-N-(4-{4-oxo-3-[2-(propan-2-yl)phenyl]-13-thiazolidin-2-yl}phenyl)benzamide

SMILES

CC(C)c(cccc1)c1N(C(c(cc1)ccc1NC(c1ccc(C(C)(C)C)cc1)=O)SC1)C1=O

InChI

InChI=1S/C29H32N2O2S/c1-19(2)24-8-6-7-9-25(24)31-26(32)18-34-28(31)21-12-16-23(17-13-21)30-27(33)20-10-14-22(15-11-20)29(3,4)5/h6-17,19,28H,18H2,1-5H3,(H,30,33)/t28-/m0/s1

InChI Key

LPQVJSKWCYAWNV-NDEPHWFRSA-N

MDL Number (MFCD)

MFCD19860511

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

472.65

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

6.971

Distribution Coefficient, logD

6.971

Water Solubility, LogSw

-5.73

Polar Surface Area

38.923

Acid Dissociation Constant (pKa)

10.99

Base Dissociation Constant (pKb)

-1.40

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

31.00

V011-5543 in Drug Discovery

Included in Screening Libraries

MDM2-p53 interaction inhibitors Library (21687 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with V011-5543 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V011-5543?
Check Price and Availability of V011-5543, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V011-5543 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V011-5543
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V011-5543
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V011-5543 available by request